I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| brush cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brush cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 36% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 341.98 | 245 / 245 | 99% | 2.54 | 499 / 502 |
| breast | 100% | 234.11 | 459 / 459 | 99% | 3.14 | 1110 / 1118 |
| esophagus | 100% | 196.77 | 1445 / 1445 | 99% | 2.97 | 181 / 183 |
| ovary | 100% | 258.28 | 180 / 180 | 99% | 2.50 | 425 / 430 |
| uterus | 100% | 273.63 | 170 / 170 | 98% | 2.40 | 451 / 459 |
| pancreas | 100% | 223.05 | 328 / 328 | 96% | 2.02 | 171 / 178 |
| lung | 100% | 211.46 | 577 / 578 | 94% | 2.16 | 1089 / 1155 |
| thymus | 100% | 222.75 | 653 / 653 | 93% | 1.79 | 564 / 605 |
| skin | 100% | 244.99 | 1809 / 1809 | 92% | 2.17 | 436 / 472 |
| bladder | 100% | 229.90 | 21 / 21 | 91% | 2.23 | 461 / 504 |
| brain | 100% | 230.24 | 2632 / 2642 | 92% | 1.93 | 647 / 705 |
| stomach | 100% | 244.22 | 359 / 359 | 91% | 1.98 | 260 / 286 |
| liver | 100% | 262.63 | 226 / 226 | 91% | 2.03 | 368 / 406 |
| kidney | 100% | 413.30 | 89 / 89 | 87% | 1.96 | 786 / 901 |
| intestine | 100% | 227.17 | 966 / 966 | 87% | 1.68 | 458 / 527 |
| adrenal gland | 100% | 232.26 | 258 / 258 | 80% | 1.35 | 183 / 230 |
| adipose | 100% | 193.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 333.45 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.90 | 1 / 1 |
| blood vessel | 100% | 179.32 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 122.74 | 842 / 861 | 0% | 0 | 0 / 0 |
| muscle | 97% | 103.31 | 780 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 1.75 | 25 / 29 |
| peripheral blood | 85% | 128.03 | 791 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 1.34 | 37 / 45 |
| eye | 0% | 0 | 0 / 0 | 70% | 1.26 | 56 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030217 | Biological process | T cell differentiation |
| GO_0015031 | Biological process | protein transport |
| GO_0098656 | Biological process | monoatomic anion transmembrane transport |
| GO_0051452 | Biological process | intracellular pH reduction |
| GO_0034702 | Cellular component | monoatomic ion channel complex |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0032580 | Cellular component | Golgi cisterna membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0008308 | Molecular function | voltage-gated monoatomic anion channel activity |
| Gene name | GPR89B |
| Protein name | G protein-coupled receptor 89A isoform C (G protein-coupled receptor 89B isoform C) G protein-coupled receptor 89B isoform A Golgi pH regulator B (Protein GPR89B) G protein-coupled receptor 89B G protein-coupled receptor 89B isoform D G protein-coupled receptor 89B isoform B |
| Synonyms | GPHRB GPR89C GPR89A HSPC201 |
| Description | FUNCTION: Voltage dependent anion channel required for acidification and functions of the Golgi apparatus that may function in counter-ion conductance . Plays a role in lymphocyte development, probably by acting as a RABL3 effector in hematopoietic cells (By similarity). . |
| Accessions | U3KPV2 X5D2I6 X5D329 P0CG08 ENST00000314163.12 ENST00000461786.5 ENST00000468618.6 X5D7G6 ENST00000491975.5 A0A087WW82 X5DNN3 A0A087WW78 |
